As shown in Figure 1B, we found that both HIF‐1α and HIF‐2α (EPAS1) have the ability to activate oncogenes deeply involved in cancer biology, such as VEGF, CXCL8 and PGR. This evidence concerns the gene CXCL8 and cancer.